Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
SNDX on Nasdaq
Keith A. Goldan - trading volume in the past year for Syndax Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Options (Right to buy) |
111K |
$1.62M |
$14.65 |
Feb 5, 2025 |
Direct |
Common Stock |
|
| Common Stock |
90.7K |
$1.41M |
$15.50 |
Feb 10, 2025 |
Direct |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.